Nymox Pharmaceutical annual debt-to-assets ratio
2018
2019
2020
2021
2022
2023
2024
Nymox Pharmaceutical Debt-to-Assets Ratio Growth & History (NYMXF)
Nymox Pharmaceutical's debt-to-assets ratio was 0.00 for fiscal 2024.
View full Nymox Pharmaceutical company overviewNymox Pharmaceutical annual debt-to-assets ratio history
| Fiscal year | Period ended | Debt-to-assets ratio | Change | Growth |
|---|---|---|---|---|
| 2024 | 2024-12-31 | 0.00 | 0.00 | — |
| 2023 | 2023-12-31 | 0.00 | 0.00 | — |
| 2022 | 2022-12-31 | 0.00 | −0.27 | — |
| 2021 | 2021-12-31 | 0.27 | 0.17 | +176.81% |
| 2020 | 2020-12-31 | 0.10 | 0.04 | +82.92% |
| 2019 | 2019-12-31 | 0.05 | 0.00 | +6.89% |
| 2018 | 2018-12-31 | 0.05 | — | — |
Nymox Pharmaceutical quarterly debt-to-assets ratio
Q4.18
Q1.19
Q2.19
Q3.19
Q4.19
Q1.20
Q2.20
Q3.20
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q3.24
Q4.24
| Fiscal quarter | Period ended | Debt-to-assets ratio | Change | YoY change |
|---|---|---|---|---|
| Q4 2024 | 2024-12-31 | 0.00 | 0.00 | — |
| Q3 2024 | 2024-09-30 | 0.00 | 0.00 | — |
| Q4 2023 | 2023-12-31 | 0.00 | 0.00 | — |
| Q3 2023 | 2023-09-30 | 0.00 | −0.00 | — |
| Q2 2023 | 2023-06-30 | 0.00 | −0.01 | — |
| Q1 2023 | 2023-03-31 | 0.00 | −0.27 | — |
| Q4 2022 | 2022-12-31 | 0.00 | −0.27 | — |
| Q3 2022 | 2022-09-30 | 0.00 | −0.11 | −96.97% |
| Q2 2022 | 2022-06-30 | 0.01 | −0.04 | −75.44% |
| Q1 2022 | 2022-03-31 | 0.27 | 0.02 | +7.39% |
| Q4 2021 | 2021-12-31 | 0.27 | 0.17 | +176.81% |
| Q3 2021 | 2021-09-30 | 0.12 | 0.10 | +622.11% |
| Q2 2021 | 2021-06-30 | 0.05 | −0.10 | −68.20% |
| Q1 2021 | 2021-03-31 | 0.25 | 0.19 | +282.46% |
| Q4 2020 | 2020-12-31 | 0.10 | 0.04 | +82.92% |
| Q3 2020 | 2020-09-30 | 0.02 | −0.01 | −44.35% |
| Q2 2020 | 2020-06-30 | 0.15 | 0.12 | +401.20% |
| Q1 2020 | 2020-03-31 | 0.07 | 0.04 | +127.04% |
| Q4 2019 | 2019-12-31 | 0.05 | 0.00 | +6.89% |
| Q3 2019 | 2019-09-30 | 0.03 | — | — |
| Q2 2019 | 2019-06-30 | 0.03 | — | — |
| Q1 2019 | 2019-03-31 | 0.03 | — | — |
| Q4 2018 | 2018-12-31 | 0.05 | — | — |
Nymox Pharmaceutical debt-to-assets ratio trends
Over the last five fiscal years, Nymox Pharmaceutical's debt-to-assets ratio decreased from 0.05 to 0.00, a change of −0.05. The latest reported quarter, Q4 2024, shows 0.00.
About the metric
What the debt-to-assets ratio means
The debt-to-assets ratio shows the portion of a company’s reported assets financed with interest-bearing debt. It is a leverage measure and should not be confused with total liabilities divided by assets.
Calculation and source
How debt-to-assets is calculated
TickerStat calculates debt-to-assets as total interest-bearing debt divided by total assets at the same reporting-period end. Periods with missing debt or non-positive assets are omitted. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Nymox Pharmaceutical source filings ↗